75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) 2 link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Shares and Stockholders' Equity (Deficit) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75070 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Shares and Stockholders' Equity (Deficit) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75080 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Reverse Recapitalization link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Balance Sheet Components link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Net Loss per Share link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Reverse Recapitalization (Tables) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Balance Sheet Components (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Net Loss per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Organization - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Reverse Recapitalization - Schedule of Acquired Assets and Assumed Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Reverse Recapitalization - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Fair Value Measurements - Summary of Balances of Promissory Note Receivable and the Corresponding CVR Liability (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Marketable Securities - Summary of Available-for-Sale Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Marketable Securities - Schedule of Maturity of Available-for Sale Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Marketable Securities - Schedule of Maturity of Available-for Sale Securities (Details) 2 link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Balance Sheet Components - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Stockholders' Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) [Default] link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Net Loss per Share - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Net Loss per Share - Summary of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Net Loss per Share - Summary of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) 2 link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Net Loss per Share - Schedule of Shares of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Net Loss per Share (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Segment Information - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Segment Information - Schedule of Disaggregated Amounts of Research and Development Expenses and General and Administrative Expenses (Details) link:presentationLink link:calculationLink link:definitionLink Related Party Transaction [Table] Balance Sheet Related Disclosures [Abstract] Scenario [Axis] Proceeds from issuance of pre-funded warrants to purchase common stock, net of issuance costs Proceeds From Issuance Of Pre Funded Warrants To Purchase Common Stock, Net Of Issuance Costs Amount of cash inflow from the issuance of pre-funded warrants to purchase common stock, net of issuance costs. Proceeds from Sale and Maturity of Marketable Securities Maturities of marketable securities Smith v. Ikena Oncology, Inc. [Member] Smith v. Ikena Oncology, Inc. [Member] Smith v. Ikena Oncology, Inc. Common Stock, Capital Shares Reserved for Future Issuance Reserve share for common stock Number of shares reserved Schedule of Accrued Liabilities [Table Text Block] Summary of Accrued Expenses and Other Current Liabilities Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Issued, Total Shares of preferred stock Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Unrecognized stock-based compensation expense for stock option awards Temporary Equity, Shares Authorized Redeemable convertible preferred stock, shares authorized Redeemable convertible preferred shares, authorized Registration Rights Agreement Registration Rights Agreement [Member] Registration rights agreement. Operating Lease, Right-of-Use Asset, Periodic Reduction Amortization of right of use-assets Commitments and Contingencies Commitments and contingencies (Note 9) Weighted Average Number of Shares Outstanding, Diluted Weighted-average common shares outstanding, diluted Total weighted-average shares outstanding Nonvoting Common Stock [Member] Non-voting Common Stock APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total General and Administrative Expense [Abstract] General and administrative: Minimum [Member] Minimum Private Placement Private Placement [Member] Private placements Proceeds from Reimbursement of Research and Development Expenses Amount of cash received during the period related to a research and development arrangement accounted for as a contract to perform research and development for others. Proceeds from Reimbursement of Research and Development Expenses Reimbursement of research and development expenses, received Payment of Issuance Costs in Connection With Reverse Recapitalization Payment of issuance costs in connection with reverse recapitalization The cash outflow for cost incurred directly with a reverse recapitalization. Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred stock, shares outstanding Fair Value, Recurring [Member] Fair Value On Recurring Basis Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block] Schedule of Acquired Assets and Assumed Liabilities Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Issued, Total Shares of common stock Segment Reporting [Line Items] CVR liability due to related party Business Combination, Contingent Consideration, Liability Business Combination, Contingent Consideration, Liability, Total Direct Program Costs Direct Program Costs [Member] Direct Program Costs Income Tax Expense (Benefit) Income Tax Expense (Benefit), Total Provision for income taxes Income tax provision (benefit) Income tax expense Income tax expense Related Party Transaction [Line Items] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Two Thousand And Twenty Five Inducement Plan [Member] Two thousand and twenty five inducement plan. 2025 Inducement Plan PIPE Financings [Member] PIPE Financings. PIPE Financing Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants issued and sold to purchase warrant shares Warrants issued and sold to purchase warrant shares Debt Securities, Available-for-Sale, Amortized Cost Amortized Cost Total Total Amortized Cost Receivable Type [Axis] Stock option contractual term Share Based Compensation Arrangement By Share Based Payment Award Annual Increase Period The period over which shares will be automatically increased annually under an equity-based payment plan, in 'PnYnMnDTnHnMnS' format. Share Based Compensation Arrangement By Share Based Payment Award Grant In Period Aggregate Grant Date Fair Value The aggregate grant-date fair value of options or other than stock (or unit) option awards granted during the reporting period. Aggregate grant-date fair value Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Effect of exchange rate changes on cash and cash equivalents Nonoperating Income (Expense) Total other income (expense), net General and Administrative Expense General and administrative Total general and administrative expense Total general and administrative expense Income Statement [Abstract] Securities Purchase Agreement [Member] Securities purchase agreement. Securities Purchase Agreement Series A non-voting convertible preferred stock. Series A Non-Voting Convertible Preferred Stock Series A Non-Voting Convertible Preferred Stock Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total Shares granted Related and Nonrelated Parties [Domain] Earnings Per Share, Basic Net loss per share, basic Earnings Per Share, Basic, Total Net loss per share attributable to common stockholders - basic Document Period End Date Document Period End Date Document Information [Table] Series B Preferred Stock [Member] Series B Preferred Stock Series B Preferred Shares Share Based Compensation Arrangement by Share Based Payment Award Annual Increase Amount The automatic increase in the number of shares that may be issued under a share-based payment arrangement on the first day of each fiscal year. Shares Increase Common Stock, Shares Authorized Common stock, shares authorized Non Rule 10b51Arr Modified [Flag] Non Rule 10b51Arr Modified. Non-Rule 10b5-1 Arrangement Modified Statement of Stockholders' Equity [Abstract] Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Prepaid expenses and other current assets Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net, Total Fair value, liability into (out of) level 3 Other Comprehensive Income (Loss), Tax [Abstract] Other comprehensive loss: Debt Instrument, Interest Rate, Stated Percentage Promissory note accrues interest at annual rate Interest rate Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Assets Total assets Maximum Cash Payments Percentage on Purchase Price in Event of Registration Failure Maximum cash payments percentage on purchase price in event of registration failure. Maximum cash payments percentage on purchase price in event of registration failure Title of 12(b) Security Title of 12(b) Security Loss Contingency, Nature [Domain] Preferred Stock, Value, Issued Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Series A convertible preferred shares - $0.00005 par value; 0 and 994,869 shares authorized, issued and outstanding as of September 30, 2025 and December 31, 2024, respectively Preferred Stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025 License Agreement Milestone Payment Per Licensed Compound Upon Achievement Of Worldwide Aggregate Cumulative Net Sales Milestones Milestone payment per licensed compound upon achievement of worldwide aggregate cumulative net sales milestones The amount due upon achievement of sales milestones for each licensed compound under a licensing agreement. Related Party Transaction [Axis] Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock upon exercise of stock options Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Stock-Based Compensation Expense Antidilutive Securities, Name [Domain] Antidilutive Securities, Name Stockholders' Equity Note, Stock Split, Conversion Ratio Reverse stock split ratio Liabilities Liabilities, Fair Value Disclosure [Abstract] Deposits and Other Assets Noncurrent The carrying amount of noncurrent assets that serve as a deposit and noncurrent assets classified as other. Deposits and other non-current assets Recapitalization Costs Merger transaction costs incurred related to reverse recapitalization Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Number of shares reserved for issuance increased Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type Proceeds from term loan Proceeds from Issuance of Long-Term Debt Proceeds from Issuance of Long-Term Debt, Total Cash and Cash Equivalents [Domain] Cash and Cash Equivalents Segment Reporting [Table Text Block] Schedule of Disaggregated Amounts of Research and Development Expenses and General and Administrative Expenses Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Increase (Decrease) in Operating Lease Liability Operating lease liabilities Operating lease liabilities Equity, Attributable to Parent Ending Balance Beginning Balance Total stockholders' equity Entity Address, Address Line Two Entity Address, Address Line Two Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative Change in right-of-use asset and lease liabilities due to contract modification Change In Right Of Use Asset And Lease Liabilities Due To Contract Modification Change in right of use asset and lease liabilities due to contract modification Earnings Per Share [Text Block] Net Loss per Share Initial Term Period [Member] Initial term period. Initial Term Period Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Due after one year through two years Number of Reportable Segments Number of reporting segment Loss Contingency, New Claims Filed, Number Number of actions filed Personnel Related Personnel Related [Member] Personnel Related Stockholders' Equity Note [Abstract] Probability Weighted Expected Future Payout Discounted Market Yield Rate Market yield percentage The market yield discount applied to the expected future payout of a note receivable to determine fair value as of the balance sheet date. Transition Services Agreement Transition Services Agreement [Member] Transition services agreement. Series A Convertible Preferred Stocks [Member] Series A Convertible Preferred Stocks. Series A Convertible Preferred Stock Stock, Class of Stock [Table] Redeemable convertible preferred shares, par value Interest Income (Expense), Nonoperating Interest Income (Expense), Nonoperating, Total Interest income (expense) Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Gains Litigation Case [Axis] Proceeds from Stock Options Exercised Proceeds from exercise of stock options Loss Contingency Nature [Axis] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Summary of Balances of Promissory Note Receivable and the Corresponding CVR Liability Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Due after one year through two years Statistical Measurement [Axis] Statistical Measurement Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Ikena CVR Agreement [Member] Ikena CVR Agreement Member. Ikena CVR Agreement Money Market Funds [Member] Money Market Funds Entity Interactive Data Current Entity Interactive Data Current Series Seed Preferred Stock [Member] Series seed preferred stock. Series Seed Preferred Stock Series Seed Preferred Shares Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year Due within one year Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] Common stock value Common Stock, Value, Issued Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Summary of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders Liabilities Total liabilities Reverse Recapitalization Business Combination [Text Block] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Summary of Financial Assets and Liabilities Measured at Fair Value Product and Service [Axis] Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Accumulated deficit Retained Earnings (Accumulated Deficit), Total Consulting and Professional Services [Member] Consulting and Professional Services Consulting and Professional Services Level 3 Fair Value, Inputs, Level 3 [Member] Other income (expense): Other Nonoperating Income (Expense) [Abstract] Maximum Percentage of Beneficial Ownership by Holder Maximum percentage of beneficial ownership by holder The maximum beneficial ownership by the holder that is allowed in order for warrants to be exercisable, as a percentage of the aggregate number of shares of voting common stock. Cash and Cash Equivalents, Fair Value Disclosure Total Cash Equivalents Legacy Inmagene Legacy Inmagene [Member] Legacy Inmagene. Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accounts Payable, Total Operating Expenses Total operating expenses Operating expense Payments Received Under Disposition Agreements [Member] Payments received under disposition agreements. Payments Received Under Disposition Agreements Revenues [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Two Thousand And Twenty Five Employee Stock Purchase Plan [Member] Two thousand and twenty five employee stock purchase plan. 2025 ESPP Business Combination, Recognized Liability Assumed, Lease Obligation Lease liabilities, current and non-current Pre-funded Warrants Pre-funded Warrants [Member] Pre-funded warrants. License Agreement Milestone Payment Per Licensed Product Upon Achievement Of Development And Regulatory Milestones License agreement milestone payment per licensed product upon achievement of development and regulatory milestones The amount due upon achievement of development and regulatory milestones for each licensed product under a licensing agreement. Temporary Equity, Ending Balance Temporary Equity, Beginning Balance Non-Voting Convertible Preferred Stock Redeemable convertible preferred shares, carrying value Redeemable convertible preferred shares Total redeemable convertible preferred shares Related Party Transactions [Abstract] Subsequent Events [Text Block] Subsequent Events Non-OX40 Divestiture Non OX40 Divestiture [Member] Non OX40 Divestiture. Series C One Preferred Stock [Member] Series C One preferred stock. Series C-1 Preferred Stock Series C-1 Preferred Shares Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV Assets, Fair Value Disclosure [Abstract] Assets Corporate Debt Securities [Member] Corporate Debt Securities Total Marketable Securities Estimated Fair Value Available-for-sale securities Total Fair Value Payments of Stock Issuance Costs Issuance costs Payment of deferred offering costs Operating Lease, Liability, Current Operating lease liabilities, current Warrants issuance cost Warrants Issuance Cost The amount of issuance cost incurred during the period for warrant shares. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year Due within one year Litigation Case [Domain] Liabilities and Equity Total liabilities and stockholders' equity Research and development Total research and development expenses Total research and development expenses Research and development expense Other Other Unallocated Expense [Member] Other unallocated expense. Document Fiscal Period Focus Document Fiscal Period Focus Interest Receivable Interest Receivable [Member] Interest Receivable. Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Revenue from Contract with Customer, Product and Service [Extensible List] Financing Receivable, after Allowance for Credit Loss Financing Receivable, after Allowance for Credit Loss, Total Note receivable value Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of Assumptions Used to Grant Date Fair Value Of Stock Options Granted Depreciation, Depletion and Amortization, Nonproduction, Total Depreciation, Depletion and Amortization, Nonproduction Depreciation and amortization expense Service Agreement Amount Paid The amount paid during the period for services under a Service Agreement. Service agreement amount paid Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type Gross proceeds from issuance of warrants Proceeds from Issuance of Warrants Gross proceeds from issuance of warrants Payments to Acquire Businesses, Net of Cash Acquired Payments to Acquire Businesses, Net of Cash Acquired, Total Cash transferred to buyer for divestiture Sale of Stock [Axis] Sale of Stock Two Thousand And Twenty Five Equity Incentive Plan [Member] Two thousand and twenty five equity incentive plan. 2025 Equity Incentive Plan Extension Term Extension Term [Member] Extension term. Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net decrease in cash and cash equivalents Net change in cash and cash equivalents Entity Current Reporting Status Entity Current Reporting Status Use of Estimates, Policy [Policy Text Block] Use of Estimates Level 1 Fair Value, Inputs, Level 1 [Member] Class of Stock [Domain] Class of Stock Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net, Total Fair value, asset into (out of) level 3 Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Summary of Outstanding Potential Common Shares Excluded in Computation of Diluted Net Loss Per Share Schedule of Shares of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Net Loss per Share Financial Instrument [Axis] Assets, Fair Value Disclosure Total assets Assets measure at fair value Total assets at fair value Document Transition Report Document Transition Report Commitments and Contingencies Disclosure [Abstract] Class of Warrant or Right [Axis] Service agreement term The period of a services agreement, in 'PnYnMnDTnHnMnS' format. Service Agreement Term Denominator: Denominator [Abstract] Denominator. Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Liabilities, Current [Abstract] Current liabilities: Share-Based Payment Arrangement [Abstract] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Balances at December 31, 2025 Balances at June 30, 2026 Common Stock Common Stock [Member] Common Stock Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Proceeds from Interest Received Proceeds from interest received Statistical Measurement [Domain] Statistical Measurement Prepaid Expense, Current Prepaid Expense, Current, Total Prepaid expenses Contingent Payments Made to Company [Member] Contingent payments made to company. Contingent Payments Made to Company Temporary Equity, Accretion of Redeemable Convertible Preferred Shares to redemption value Temporary Equity, Accretion to Redemption Value Accretion of redeemable convertible preferred shares Equity, Attributable to Parent [Abstract] Stockholders' equity: Weighted Average Number of Shares Outstanding, Basic Weighted-average common shares outstanding, basic Weighted Average Number of Shares Outstanding, Basic, Total Weighted-average common stock outstanding Number of business days within agreement agreed to be prepared and filed Number of Business Days within Agreement Agreed to be Prepared and Filed The period in which the Company is required to prepare and file the specified agreement, in 'PnYnMnDTnHnMnS' format. Number of business days within agreement agreed to be prepared and filed Assets [Abstract] Assets Entity Central Index Key Entity Central Index Key Entity Central Index Key Antidilutive Securities [Axis] Antidilutive Securities Rule 10b51 Arr Modified [Flag] Rule 10b51 Arr Modified. Rule 10b5-1 Arrangement Modified Class of Stock [Line Items] Accrued other Other Liabilities, Current Current Fiscal Year End Date Current Fiscal Year End Date Class of Warrant or Right [Domain] Document Quarterly Report Document Quarterly Report Earnings Per Share, Diluted, by Common Class, Including Two-Class Method [Table] Net Income (Loss) Available to Common Stockholders, Diluted Diluted Net loss attributable to common stockholders Net loss attributable to common stockholders - diluted Cash and Cash Equivalents [Axis] Cash and Cash Equivalents Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total Change in fair value Reimbursement of research and development expenses Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Fair Value, Inputs, Level 2 [Member] Level 2 Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent Cash and cash equivalents Business Combination [Abstract] Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Net cash used in operating activities Net cash used in operating activities Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Earnings Per Share, Diluted Net loss per share, diluted Earnings Per Share, Diluted, Total Net loss per share attributable to common stockholders - diluted Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred stock, par value per share Net loss Net loss Clinical Trial Deposits [Member] Clinical Trial Deposits. Clinical Trial Deposits Potential Milestone License Proceeds Used to Pay Note Receivable Percentage The amount of proceeds from milestone or license payments received that may be required to be used to prepay the outstanding balance of a note receivable, as a percentage of the proceeds. Potential milestone license proceeds used to pay note receivable percentage Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Cash, Cash Equivalents, and Short-Term Investments Cash, Cash Equivalents, and Short-Term Investments, Total Cash, cash equivalents and marketable securities Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Comprehensive Income (Loss), Net of Tax, Attributable to Parent Total comprehensive loss Incremental Common Shares Attributable To Conversion Of Pre Funded Warrants Incremental common shares attributable to conversion of pre funded warrants Weighted-average common shares outstanding under the pre-funded warrants Measurement Frequency [Domain] Measurement Frequency Facilities Related and Other [Member] Facilities Related and Other Facilities Related and Other Scenario [Domain] Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total Foreign currency translation adjustment Equity Components [Axis] Equity Components Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Cash flows from investing activities: Statement of Cash Flows [Abstract] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV Stockholders' Equity, Reverse Stock Split Reverse stock split Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Prepaid Expense and Other Assets, Total Prepaid expenses and other current assets Fair Value Disclosures [Text Block] Fair Value Measurements Preferred Stock, Shares Authorized Preferred stock, shares authorized OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Unrealized loss on marketable securities Unrealized loss on marketable securities Class of Stock [Axis] Class of Stock Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive securities excluded from computation of earnings per share amount Number of Operating Segments Number of operating segment AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Common Stock, Capital Shares Reserved for Future Issuance Shares available for grant under the plan Accrued Research And Development Expenses Current Carrying value as of the balance sheet date of obligations incurred and payable for research and development expenses. Accrued external research and development expenses Temporary Equity, Ending Balance, Shares Temporary Equity, Beginning Balance, Shares Temporary equity, shares outstanding Redeemable convertible preferred stock, shares outstanding Redeemable convertible preferred shares, outstanding Receivable [Domain] Legacy Inmagene CVR Agreement Legacy Inmagene CVR Agreement [Member] Legacy Inmagene CVR Agreement Member. Exchange ratio in a reverse recapitalization of shares converted Exchange Ratio In A Reverse Recapitalization Of Shares Converted The amount of shares received upon conversion of one share of stock in a reverse recapitalization. Underwritten registered offering. Underwritten Registered Offering [Member] URO Underwritten Registered Offering Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other current liabilities Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Gross Unrealized Losses Document Type Document Type Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash flows from operating activities: Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Options to Purchase Common Stock Accounting Standards Update [Extensible Enumeration] Operating Income (Loss) Loss from operations Sale of Stock, Price Per Share Reverse Stock Split, at a price Balance Sheet Related Disclosures [Line Items] Balance sheet related disclosures. Segment Reporting [Table] Entity File Number Securities Act File Number Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false] Accrued Liabilities and Other Liabilities Accrued expenses and other current liabilities Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Location, Statement of Income, Balance [Axis] Retained Earnings [Member] Accumulated Deficit Investment in Debt and Equity Securities and Other Trading Assets [Text Block] Marketable Securities Entity Registrant Name Entity Registrant Name Business Combination, Recognized Asset Acquired, Other Asset, Noncurrent Other non-current assets Accounting Policies [Abstract] Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Net Assets Net assets Entity Address, Address Line One Entity Address, Address Line One Redeemable Convertible Preferred Stock [Member] Redeemable Convertible Preferred Stock Redeemable convertible preferred shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Options exercised Number of Shares, Exercised Issuance of common stock upon exercise of stock options, (in Shares) Assets, Current Total current assets Fair Value, Recurring and Nonrecurring [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] CVR Holder Proceeds Percentage Amount due to a Contingent Value Rights holder upon specified events, as a percentage of net proceeds. CVR holder proceeds percentage Loss Contingencies [Line Items] Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information: Related Party Transactions Disclosure [Text Block] Related Party Transactions Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) Net assets acquired Entity Small Business Entity Small Business Numerator [Abstract] Numerator. Numerator: Promissory Note [Member] Promissory note. Promissory Note Accretion of Redeemable Convertible Preferred Shares to redemption value Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease), Total Change in fair value Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized stock-based compensation expense for stock option awards Regulated Operation, Inventory [Table] Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Change in Accounting Principle, Accounting Standards Update, Adoption Date Employee-related Liabilities, Current Employee-related Liabilities, Current, Total Accrued compensation Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Earnings Per Share [Abstract] Net loss per common share, basic and diluted Indemnification Agreement [Member] Indemnification Agreements Unvested Restricted Stock Units [Member] Unvested restricted stock units. Unvested restricted stock units Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Stock Option Activity 2026 Private Placement Two Thousand And Twenty Six Private Placement [Member] Two thousand and twenty six private placement member. Plan Name Plan Name [Axis] Loss Contingency Accrual Loss Contingency Accrual, Ending Balance Loss Contingency Accrual, Beginning Balance Accrued liabilities of claims Product and Service [Domain] Business Combination, Recognized Asset Acquired, Operating Lease Right-of-use Assets, Net Operating lease right-of-use assets, net Amount of lease assets assumed in a business combination and recognized at the acquisition date. Stockholders' Equity Equity [Text Block] Measurement Frequency [Axis] Measurement Frequency Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash flows from financing activities: Kent v. Ikena Oncology, Inc. [Member] Kent v. Ikena Oncology, Inc. [Member] Kent v. Ikena Oncology, Inc. Equity Unit Purchase Agreements [Member] Options to purchase common stock Entity Tax Identification Number Entity Tax Identification Number Accounts Receivable [Member] Accounts Receivable Equity Component [Domain] Equity Component Entity Address, City or Town Entity Address, City or Town Redeemable convertible preferred shares (as converted to ordinary shares) Redeemable Convertible Preferred Shares [Member] Redeemable convertible preferred shares. Increase (Decrease) in Contract with Customer, Liability Deferred revenue Business Combination, Recognized Liability Assumed, Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities Amount of expenses incurred but not yet paid nor invoiced and liabilities classified as other, assumed in a business combination and recognized at the acquisition date. Business Acquisition Business Combination [Axis] Income Tax Paid, after Refund Received Income Taxes Paid, Net, Total Cash paid for income taxes, net Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Investments Classified by Contractual Maturity Date [Table Text Block] Schedule of Maturity of Available-for Sale Securities Marketable Securities [Table Text Block] Summary of Available-for-Sale Securities Increase (Decrease) in Deposits and Other Noncurrent Assets Deposits and other non-current assets Amount of increase (decrease) in deposits and non-current assets classified as other. Series C Two Preferred Stock [Member] Series C Two preferred stock. Series C-2 Preferred Shares Increase (Decrease) in Other Noncurrent Liabilities Other non-current liabilities Business Combination, Recognized Asset Acquired, Marketable securities Marketable securities Amount of marketable securities acquired in a business combination and recognized at the acquisition date, classified as current. Antidilutive Security, Excluded EPS Calculation [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted-average common shares outstanding, basic and diluted Payments to Acquire Marketable Securities Purchase of marketable securities Payments to Acquire Marketable Securities, Total Purchases of marketable securities Statement [Table] Statement [Table] Share-Based Payment Arrangement, Expense Total stock-based compensation expense Stock-based compensation expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income taxes Loss before income taxes Affiliated Entity [Member] Affiliated Entity Entity Shell Company Entity Shell Company Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash used in investing activities Statement [Line Items] Statement [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Maximum [Member] Maximum Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current Prepaid expenses and other current assets Sale of Stock [Domain] Sale of Stock Redeemable convertible preferred stock, shares issued Temporary Equity, Shares issued Redeemable convertible preferred shares, issued Loss Contingency, Lawsuit Filing Date Lawsuit filing date Business Combination [Domain] Business Acquisition, Acquiree Common Shares Under Pre Funded Warrants [Member] Common Shares Under Pre Funded Warrants. Common Shares Under Pre Funded Warrants Subsequent Events [Abstract] CVR Liability [Member] CVR Liability. CVR Liability Investments, Debt and Equity Securities [Abstract] Note receivable maturity year The year in which a note receivable becomes due. Note Receivable Maturity Year Current assets: Assets, Current [Abstract] Liabilities of Business Transferred under Contractual Arrangement, Noncurrent CVR liability due to related party Liabilities, Fair Value Disclosure Total liabilities at fair value Liabilities measured at fair value Accrued Professional Fees, Current Accrued consulting and professional fees Related Party Transaction [Domain] Marketable Securities [Line Items] Issuance Of Pre Funded Warrants For The Purchase Of Common Stock Value of pre-funded warrants issued. Issuance of pre-funded warrants for the purchase of common stock Accrued expenses and other current liabilities. Accrued Expenses And Other Current Liabilities [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus Gain (Loss) on Disposition of Business Gain (loss) on disposition of business Accretion (Amortization) of Discounts and Premiums, Investments Net accretion of discounts on marketable securities Accretion of discounts on marketable securities, net Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common stock, shares outstanding Collaborative Arrangement and Arrangement Other than Collaborative [Table] Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Financial Instruments [Domain] Business Combination [Line Items] Accrued Financing Costs Carrying value as of the balance sheet date of obligations incurred and payable for financing costs. Related Party [Member] Related Party Forecast Forecast [Member] Entity Ex Transition Period Entity Ex Transition Period Business Combination, Recognized Liability Assumed, Other Liability, Noncurrent Other non-current liabilities Change in Accounting Principle, Accounting Standards Update, Adopted [true false] Operating Lease, Liability, Noncurrent Operating lease liabilities, non-current Security Exchange Name Security Exchange Name Related and Nonrelated Parties [Axis] New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrants issued Warrants exercise price Entity Address, State or Province Entity Address, State or Province Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized stock-based compensation expense for stock option awards expected to be recognized period Series A Non-Voting Convertible Preferred Stock Series A Preferred Shares Series A Convertible Preferred Shares Loss Contingency, Allegations Legal proceedings allegations Temporary Equity, Accretion to Redemption Value, Adjustment Accretion of redeemable convertible preferred shares Accretion of redeemable convertible preferred shares Less: accretion of redeemable convertible preferred shares Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Number of stock authorized Paid-in-Kind Interest Non-cash interest expense Operating Lease, Right-of-Use Asset Operating lease right-of-use assets, net Amendment Flag Amendment Flag Loss Contingencies [Table] Share-Based Payment Arrangement [Text Block] Stock-Based Compensation Debt Instrument [Axis] Asset sales Other Nonoperating Income (Expense), Total Other income related to subleases Other income , net Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash, cash equivalents and restricted cash, end of period Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Voting Common Stock [Member] Voting Common Stock Voting Common Stock Corporate Bond Securities [Member] Corporate bonds City Area Code City Area Code Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block] Summary of Restricted Stock Unit Activity Preferred Stock [Member] Preferred Stock Organization, Consolidation and Presentation of Financial Statements [Abstract] Proceeds from Issuance of Common Stock Proceeds from issuance of common stock for underwritten registered offering, net of offering costs Aggregate gross proceeds Research and Development Expense [Abstract] Research and development: Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent, Total Operating Expenses [Abstract] Operating expenses: Miragene [Member] Miragene member. Miragene Deferred Offering Costs Included in Accounts Payable and Accrued Expenses and Other Current Liabilities Deferred offering costs included in accounts payable and accrued expenses and other current liabilities. Deferred offering costs included in accounts payable and accrued expenses and other current liabilities Stock-Based Compensation Stock-based compensation [Member] Stock-based compensation Common Stock, Par or Stated Value Per Share Common stock, par value Closing Stock Price of Company's Common Stock Liabilities, Current Total current liabilities Financing Receivable, after Allowance for Credit Loss, Noncurrent, Total Promissory note receivable Promissory note receivable from related party (Note 8) Promissory note receivable from related party Temporary Equity, Liquidation Preference Redeemable convertible preferred stock, liquidation preference Hutchmed Agreement [Member] Hutchmed Agreement. Hutchmed Agreement Uncertain Tax Positions [Member] Uncertain tax positions. Uncertain Tax Positions Segment Reporting [Text Block] Segment Information Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Class of Warrant or Right, Purchase Price of Warrants or Rights Purchase price of warrants The per share amount received for each warrant share sold. Purchase price of warrants Trading Symbol Trading Symbol Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock Weighted-average Series A convertible preferred outstanding Increase in Carrying Amount of Redeemable Preferred Stock Accretion of Redeemable Convertible Preferred Shares to redemption value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Number of Shares, Granted Shares granted Entity Emerging Growth Company Entity Emerging Growth Company Additional Paid-in Capital [Member] Additional Paid-in Capital Plan Name [Domain] Plan Name Other Liabilities, Noncurrent Other non-current liabilities Other non-current liabilities Number of shares granted or purchased Stock Issued During Period, Shares, Employee Stock Purchase Plans Other [Member] Other. Other US Treasury Securities [Member] U.S. Treasury Securities Business Combination [Table] Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of noncash investing and financing activities: Cover [Abstract] Accretion of Redeemable Convertible Preferred Shares Accretion of redeemable convertible preferred shares. Less: accretion of redeemable convertible preferred shares Accretion of redeemable convertible preferred shares Less: accretion of redeemable convertible preferred shares Marketable Securities [Table] Accumulated Other Comprehensive Income (Loss), Net of Tax Total other comprehensive loss Accumulated other comprehensive income (loss) Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Share-based Payment Arrangement, Noncash Expense, Total Additional Paid in Capital Additional Paid in Capital, Ending Balance Additional Paid in Capital, Beginning Balance Additional paid-in capital Additional Paid in Capital, Total Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Fair Value Disclosures [Abstract] Cash and Cash Equivalent Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by (used in) financing activities Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Beginning Balance - January 1, 2025 Balances at March 31, 2026 Balances at December 31, 2025 Balances at June 30, 2026 Business Combination, Recognized Liability Assumed, Accounts Payable, Current Accounts payable Sale of Stock, Percentage of Ownership before Transaction Percentage of stockholders owning company's sotck Net Income (Loss) Available to Common Stockholders, Basic Basic Net loss attributable to common stockholders Net loss attributable to common stockholders Net loss attributable to common stockholders The automatic increase in the number of shares that may be issued under a share-based payment arrangement on the first day of each fiscal year, as a percentage of shares outstanding. Share Based Compensation Arrangement By Share Based Payment Award Annual Increase Percentage Available for issuance percentage of annual increase in number of common stock outstanding Entity Filer Category Entity Filer Category Debt Instrument, Name [Domain] Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description CODM description Two Thousand Twenty Five PIPE Financing [Member] Two thousand twenty five PIPE financing. 2025 PIPE Financing Marketable Securities, Current Marketable securities Revenue from Contract with Customer, Excluding Assessed Tax Revenue from Contract with Customer, Excluding Assessed Tax, Total License revenue Shares, Outstanding Ending Balance, Shares Beginning Balance, Shares Common stock, shares outstanding Document Information [Line Items] Segment Reporting [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Statement of Financial Position [Abstract] Ikena Oncology, Inc Ikena Oncology Inc [Member] Ikena oncology inc. Local Phone Number Local Phone Number Accounting Standards Update 2025-05. Accounting Standards Update 2025-05 [Member]